DRG:HYBRID-XL^® erstmalig ausgestellt auf "Pharmed and Healthcare Vietnam"

News-Text von DRG International:

Unique, fully-automatic, random access analyzer for immunoassays and clinical chemistry unveiled with Vietnamese distributor, Phu Gia

DRG Intl. recently exhibited the revolutionary DRG:HYBRiD.XL to rave reviews at the "Pharmed and Healthcare Vietnam".
The event, held in Ho Chi Minh City, hosted medical device companies, distributors and consumers from September 26-29.

DRG Intl. was represented by Julia Räder of DRG Instruments GmbH, DRG's subsidiary in Germany.
Mrs. Raeder discussed DRG's full line of immunoassays and premiered a working model of the DRG:HYBRiD.XL automatic analyzer.
"The equipment was displayed and demonstrated to the visitors with great success," said Cyril Geacintov, Ph.D., Founder and CEO of DRG International. "We are excited to bring this highly-valuable equipment to shows all over the world throughout the coming year."

Working with Mrs. Räder at the event were the team from Phu Gia, the company that will be the official distributor of the DRG:HYBRiD.XL in Vietnam. "Phu Gia has been very active in promoting and distributing the wide range of DRG kits, manufactured and developed by DRG, in their country, and we look forward to working with them on the DRG:HYBRiD.XL as well," said Dr. Geacintov.

The DRG:Hybrid-XL is designed to provide ease of use in all aspects of testing.
The analyzer is controlled by an easy-to-read touch screen monitor run by software that offers simple user navigation.
Depending upon the test type, the results can be read in as little as 10 minutes, which is ideal for on-site decisions involved with emergency procedures.

Currently DRG is in the process of validating a wide range of possible tests for use in a variety of areas of medical expertise.

Das Phu Gia - Team mit Julia Räder